Skip to main content

Table 3 Association between the percentage of surface receptors and cytotoxic granules positive NK cells and the clinicopathological features of pancreatic cancer

From: Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer

Pancreatic cancer

 

NO. of patients

NKG2D

NKp30

NKp46

Perforin

KIR3DL1

  

%

P

%

P

%

P

%

P

%

P

Distant metastasis

           

Absent

20

82.6 ± 9.5

ns T

44.2 ± 19.3

ns T

53.8 ± 23.4

ns T

80.5 ± 16.8

ns U

20.6 ± 12.1

ns U

Present

11

85.5 ± 6.4

 

50.7 ± 22.1

 

60.9 ± 20.2

 

78.7 ± 15.0

 

18.4 ± 10.3

 

Non-metastatic Pancreatic cancer

 

NO. of patients

NKG2D

NKp30

NKp46

Perforin

KIR3DL1

  

%

P

%

P

%

P

%

P

%

P

Histological grade

           

Well/Moderately

9

85.4 ± 8.9

ns T

46.2 ± 27.1

ns T

71.4 ± 17.4

< 0.01 U

85.3 ± 8.5

ns U

23.2 ± 13.6

ns U

Poorly

11

79.6 ± 9.1

 

40.6 ± 12.4

 

39.5 ± 17.1

 

76.5 ± 21.0

 

18.6 ± 10.8

 

Depth of invasion *

           

Tis/T1/T2

11

84.3 ± 7.6

ns T

41.2 ± 18.2

ns T

54.4 ± 22.6

ns T

75.2 ± 19.1

ns U

18.7 ± 10.4

ns T

T3

9

79.7 ± 10.9

 

46.0 ± 22.9

 

53.2 ± 25.6

 

86.9 ± 11.6

 

23.0 ± 14.1

 

Lymph node metastasis

           

Absent

6

89.9 ± 5.6

< 0.05 T

58.1 ± 19.0

< 0.05 T

60.9 ± 22.6

ns T

80.9 ± 21.7

ns U

27.0 ± 15.5

ns T

Present

14

78.9 ± 8.6

 

37.8 ± 17.7

 

50.8 ± 23.8

 

80.3 ± 15.3

 

17.9 ± 9.7

 

Blood vessel invasion

           

Absent

13

86.7 ± 6.7

< 0.01 T

40.3 ± 22.7

ns U

54.7 ± 24.9

ns U

86.2 ± 12.9

< 0.05 U

21.9 ± 14.4

ns U

Present

7

73.9 ± 7.6

 

48.4 ± 13.7

 

52.2 ± 22.1

 

69.9 ± 19.1

 

18.3 ± 6.1

 

Nerve invasion

           

Absent

6

86.9 ± 5.7

ns T

36.2 ± 22.6

ns U

60.5 ± 27.6

ns U

78.1 ± 16.1

ns U

15.9 ± 5.6

ns T

Present

14

80.2 ± 9.9

 

45.9 ± 19.0

 

51.0 ± 21.8

 

81.5 ± 17.6

 

22.7 ± 13.6

 
  1. *According to 2010 American Joint Committee on Cancer (AJCC), T4 pancreatic cancer invades celiac artery or superior mesenteric artery, and is unresectable, so T4 is not enrolled in depth of invasion for non-metastatic pancreatic cancer. Tis, T1, or T2 pancreatic cancer invades inside of the pancreas; T3 pancreatic primary cancer invades outside of the pancreas. U represented Mann–Whitney U-tests and T represented independent t-tests. Data were expressed as means ± standard deviations (Mean ± SD).